Company: SATT
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001683168-25-002119
Chunk: 183

Company: SATIVUS TECH CORP.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1C
Chunk 183
---
 dependable yield of saffron, maintaining consistent quality and quantity in a cost-effective
manner.

Saffron finds application across multiple sectors,
notably within the culinary realm where it is favored by renowned chefs and Michelin-starred establishments, the natural cosmetics sector,
and the nutraceuticals industry. The recognition of saffron for its medicinal properties, including its use as an antidepressant, antioxidant,
and antiseptic, is on the rise.

 7 

The total Saffron Tech market opportunity evaluated
as $2.3B in 2023, and is anticipated to grow up to $3.7B by 2032. The market opportunity is based on the Saffron Marker, Saffron extraction
market, and potential segments in the nutraceutical and cosmetical use markets.

In April 2022, Saffron Tech announced its new
state-of-the-art indoor research and development center is operational. As of April 2022 Saffron Tech successfully completing four Saffron
cultivation cycles a year, using CEA, while traditional agriculture only produces one harvest of saffron per year.

On December 9, 2021, we implemented a 1-for-10
consolidation, or reverse split, of our issued and outstanding common shares. Except where otherwise indicated, all share and per share
data in this 10-K have been retroactively restated to reflect the reverse stock split.

On December 13, 2021,
the Company changed its name from Seedo Corp to Sativus Tech Corp. On the same day the Company also announced the appointment of Tal Wilk-Glazer
as the CEO of Saffron Tech. Wilk-Glazer joins Saffron-Tech after finishing her job at Salesforce as Salesforce’s Industries Eastern
Europe, Africa and Israel regional director.

On January 6, 2022, the Company announced that
its subsidiary, Saffron Tech, has planted approximately 25,000 Saffron bulbs in fields in the Golan Heights, in Norther Israel. The plantation
is being managed in conjunction with the Shamir Research Institute, which operates under the auspices of the Haifa University, Israel.

On April 4, 2022,
the Company announced that Mr. Moshe Bar Siman Tov and Mrs. Iris Tova Ginsburg have resigned from the Board of Directors of the Company,
and immediately appointment of Mrs. Tal Wilk-Glazer